Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| May 30, 2007 | Ten Percent Owner | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 30, 2007 | Senior VP, Drug Development | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 48,866 | |
| May 30, 2007 | Senior VP, Drug Development | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 6,666 | |
| May 30, 2007 | Senior VP, Drug Development | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 30, 2007 | Senior VP, Drug Development | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 30, 2007 | Senior VP, Drug Development | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 30, 2007 | Senior VP, Drug Development | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 30, 2007 | Chief Operating Officer | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 32,000 | |
| May 30, 2007 | Chief Operating Officer | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 30, 2007 | Chief Operating Officer | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.